Decision Sciences Medical

Executive Summary

Decision Sciences Medical is a private San Diego-based company developing the Acoustic Coherent Tomography (ACT) imaging platform, a novel ultrasound-based technology that aims to transform medical imaging for diagnosis, surgical planning, intraoperative guidance, and postoperative monitoring. The ACT platform leverages advanced coded waveforms, wide-aperture imaging, and tomography to provide high-resolution, real-time visualization without ionizing radiation, potentially addressing unmet needs in musculoskeletal, cardiovascular, and soft tissue imaging. Founded in 2009, the company has remained under the radar with limited public information on funding, partnerships, or regulatory milestones. Its differentiation lies in combining acoustic coherence with tomographic reconstruction, which could enable new clinical applications where conventional ultrasound or MRI/CT fall short. However, the lack of disclosed clinical or commercial traction suggests the platform is still in early development. If validated, ACT could compete in the advanced imaging market, but significant regulatory and technical hurdles remain.

Upcoming Catalysts (preview)

• Q3 2026First-in-human clinical study initiation40% success
• Q4 2026Series A or B funding round50% success
• Q1 2027Pre-submission meeting with FDA for 510(k) clearance pathway60% success